£91.00

Springer The Rho GTPases in Cancer

26550459

Price data checked 4 days ago

View at Amazon

Price History & Forecast

Last 87 days • 87 data points (No recent data available)

Historical
Generating forecast...
£91.00 £83.89 £85.44 £86.99 £88.55 £90.10 £91.65 27 January 2026 17 February 2026 11 March 2026 01 April 2026 23 April 2026

Price Distribution

Price distribution over 87 days • 3 price levels

Days at Price
Current Price
14 days 23 days 50 days · current 0 13 25 38 50 £85 £89 £91 Days at Price

Price Analysis

Most common price: £91 (50 days, 57.5%)

Price range: £85 - £91

Price levels: 3 different prices over 87 days

Description

Product Description Channing Der and colleagues provide an encyclopedic overview of the Rho GTPases, providing enough detail to make any reader well-versed in the Rho field. Finally, Sofia Merajver’s laboratory provides an overview, which details the roles of the Rho proteins in cancer progression. She provides us with the history of the study of the Rho GTPases, their regulatory and effector proteins in cancer and gives us a benchmark of where the field is today. The second section of the book details the current knowledge of the Rho regu- tory proteins in cancer progression: aberrant expression and activation of these proteins leads to dysfunctional Rho signaling and a cancer phenotype. Gary Bokoch’s laboratory has provided a detailed overview of the role of Rho guanine dissociation inhibitors (GDIs) in cancer. These molecules are involved in preventing the Rho protein from associating with the inner plasma membrane and exchanging GDP for GTP, and thus becoming active. Next, Tozu Kazasa’s labo- tory has worked on the link between heterotrimeric G proteins and Rho activation via the RGS–RhoGEFs. This aspect of Rho activation is particularly interesting in that heterotrimeric G proteins and their associated G-protein-coupled receptors are attractive and attainable therapeutic targets. Dan Billadeau’s laboratory has worked extensively on the Vav RhoGEFs, which are potent oncogenes in their own right. From the Back Cover The Rho GTPases in Cancer is the first volume to collect and summarize the current understanding of the Rho GTPases and their involvement in the progression of human cancer. The critical role of the Rho GTPases, their regulatory proteins, and their effectors in cancer progression has become increasingly evident over the past decade. As translational research increases on these proteins, their importance as keystone molecules in vital cellular process is highlighted. Thus, these molecules represent a major class of potential therapeutic targets that could be exploited clinically. This aspect of Rho GTPase biology is developing, therefore the contents of The Rho GTPases in Cancer should prove of interest to clinicians and members of the cancer research community wishing to develop new treatments for cancer.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Advances in Cancer Research: 84: Volume 84
94% match

Advances in Cancer Research: 84: Volume 84

Academic Press

£26.76 09 Mar 2026
Springer Rho GTPases - Molecular Biology Intelligence Unit
94% match

Springer Rho GTPases - Molecular Biology Intelligence Unit

Springer

£114.98 25 Apr 2026
Rho GTPases: Methods and Protocols: 827 (Methods in Molecular Biology, 827)
94% match

Rho GTPases: Methods and Protocols: 827 (Methods in Molecular Biology, 827)

Humana

£73.87 09 Mar 2026
RAS Family GTPases: 4 (Proteins and Cell Regulation, 4)
94% match

RAS Family GTPases: 4 (Proteins and Cell Regulation, 4)

Springer

£129.76 09 Mar 2026
RAS Family GTPases: 4 (Proteins and Cell Regulation, 4)
94% match

RAS Family GTPases: 4 (Proteins and Cell Regulation, 4)

Springer

£130.46 09 Dec 2025
Springer Ras Superfamily Small G Proteins - Biology and Mechanisms
94% match

Springer Ras Superfamily Small G Proteins - Biology and Mechanisms

Springer

£129.99 26 Apr 2026
Humana Rho GTPases: Methods and Protocols - Volume 827
94% match

Humana Rho GTPases: Methods and Protocols - Volume 827

Humana

£102.16 18 Apr 2026
Stress Response Pathways in Cancer: From Molecular Targets to Novel Therapeutics
94% match

Stress Response Pathways in Cancer: From Molecular Targets to Novel Therapeutics

Springer

£107.67 07 Jan 2026
Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development)
93% match

Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development)

Humana

£143.79 09 Mar 2026
Cancer Genomics: Molecular Classification, Prognosis and Response Prediction
93% match

Cancer Genomics: Molecular Classification, Prognosis and Response Prediction

Springer

£132.00 12 Jan 2026
Pharmaceutical Perspectives of Cancer Therapeutics
93% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£139.95 11 Jan 2026
Stem Cells and Cancer (Cancer Drug Discovery and Development)
93% match

Stem Cells and Cancer (Cancer Drug Discovery and Development)

Humana

£149.20 27 Jan 2026
Humana PI3K-mTOR in Cancer and Cancer Therapy Book
93% match

Humana PI3K-mTOR in Cancer and Cancer Therapy Book

Humana

£113.94 25 Apr 2026
Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (Cancer Drug Discovery and Development)
93% match

Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (Cancer Drug Discovery and Development)

Humana

£84.39 21 Feb 2026
Stem Cells and Cancer (Cancer Drug Discovery and Development)
93% match

Stem Cells and Cancer (Cancer Drug Discovery and Development)

Humana

£148.78 19 Apr 2026
Prostate Cancer: Cellular and Genetic Mechanisms of Disease Development and Progression: 1210 (Advances in Experimental Medicine and Biology, 1210)
93% match

Prostate Cancer: Cellular and Genetic Mechanisms of Disease Development and Progression: 1210 (Advances in Experimental Medicine and Biology, 1210)

Springer

£163.67 20 Apr 2026
Next Generation Kinase Inhibitors: Moving Beyond the ATP Binding/Catalytic Sites
93% match

Next Generation Kinase Inhibitors: Moving Beyond the ATP Binding/Catalytic Sites

Springer

£91.63 09 Mar 2026
Proteases and Cancer: Methods and Protocols: 539 (Methods in Molecular Biology, 539)
93% match

Proteases and Cancer: Methods and Protocols: 539 (Methods in Molecular Biology, 539)

Humana

£90.49 17 Feb 2026
CRC Press Rediscovering Cancer: From Mechanism to Therapy
93% match

CRC Press Rediscovering Cancer: From Mechanism to Therapy

CRC Press

£112.08 14 Apr 2026
Cancer RNome: Nature & Evolution
93% match

Cancer RNome: Nature & Evolution

Springer

£107.85 07 Mar 2026
Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)
93% match

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Humana

£72.83 08 Mar 2026
Mechanisms of Oncogenesis: An update on Tumorigenesis: 12 (Cancer Growth and Progression, 12)
93% match

Mechanisms of Oncogenesis: An update on Tumorigenesis: 12 (Cancer Growth and Progression, 12)

Springer

£93.06 10 Mar 2026
Rediscovering Cancer: From Mechanism to Therapy
93% match

Rediscovering Cancer: From Mechanism to Therapy

CRC Press

£76.70 26 Feb 2026
Molecular Biology of Human Cancers
93% match

Molecular Biology of Human Cancers

£76.67 12 Jan 2026